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ABSTRACT 
Cannabis is one of the most commonly used recreational drugs among adolescents and young 
adults. Exposure to cannabis and its primary psychoactive component delta-9-
tetrahydrocannabinol (THC) may induce modifications in neural circuitry that in turn lead to 
adverse consequences on behavior.  Previous literature has suggested that intraperitoneal, 
intragastric, or subcutaneous administration of THC may produce an anxiogenic effect and 
reduce locomotor activity in rats, but it is unclear if this also occurs following volitional, oral 
intake of THC.  Here, we used adolescent and adult rats of both sexes to determine if oral THC 
would alter locomotor activity in an open-field arena (OFA) and anxiety-like behavior on an 
elevated plus maze (EPM).  Subjects received vehicle- or THC-impregnated crackers (3.0, 5.0, 
and 10.0 mg/kg) starting on either P35-37 for adolescent-onset groups or P79-81 for adult-onset 
groups 90 min prior to each behavioral test.  Our data suggests that THC induced a dose- 
dependent decrease in locomotor activity in the OFA.  Additionally, drug-treated animals 
differed in time spent in the open arms in the EPM, however these results were not statistically 
significant.  These locomotor effects appear to be dependent on both age and sex, as adult males 
exhibited a relatively greater sensitivity to the effects of THC compared to adult females.  
Furthermore, these results suggest that rats will voluntarily consume THC-laced crackers at 
doses that influence locomotor activity and anxiety-related behavior.   
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INTRODUCTION 
Cannabis is one of the most commonly used recreational drugs among adolescents, and 
its main psychoactive constituent is Δ9-tetrahydrocannabinol (THC).  Approximately 47% of 
adolescents and young adults ranging from ages 12-26 have reported using cannabis at least once 
in the past year (National Institute of Health [NIH], 2019).  Furthermore, state-level recreational 
legalization of cannabis is becoming more widely accepted in the United States (Hopfer, 2014).  
Therefore, due to the decreasing stigma of using cannabis, individuals may be more inclined to 
partake in this drug and engage in different cannabis use practices (Giombi et al., 2018).  Oral 
intake via edibles has become increasingly popular (Barrus et al., 2016), yet knowledge about the 
potential health risks from this route of administration is limited.  There is a clear need to 
examine the consequences of cannabis consumption in adolescents, as they may be particularly 
vulnerable to the potential transient and long-term effects. 
Compared to adults, adolescents are more likely to initiate drug use and develop 
substance use disorders (Casey et al. 2008).  Current theories have proposed unbalanced neural 
structures, where an underdeveloped prefrontal cortex (PFC) coupled with mature nucleus 
accumbens (NAc) underlies adolescent impulsivity in reward seeking (Steinberg et al., 2009).  
For example, functional magnetic imaging studies (fMRIs) have demonstrated that adolescents 
tend to have greater activation of limbic regions during reward processing compared to adults.  
Galvan et al. (2006) assessed behavioral and neural responses to rewards and showed that 
adolescents had enhanced neural activity in the NAc and greater recruitment of neurons in the 
orbital frontal cortex (OFC).  Evidence from cognitive tasks such as Stroop and Go/NoGo have 
already shown that adolescents display increased patterns of neuronal activity in brain areas that 
reflect cognitive control compared to adults; therefore, greater and more dispersed neural activity 
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in the OFC suggest an underdeveloped structure (Casey et al., 2005).  Indeed, fine-tuned neural 
activity indicates a mature brain structure. These findings reflect a disproportional system where 
subcortical regions mature much sooner than cortical regions, ensuring an increased motivation 
for rewards during adolescence.   
Rodent models have provided mixed findings regarding adolescent hypersensitivity to 
reward.  In an experiment of cocaine self-administration, adolescent rats lever pressed more for 
cocaine than their adult counterparts, even during periods of signaled non-availability (Anker et 
al., 2011).  This increased non-reinforced responding may be indicative of increased reward 
salience and reduced inhibitory control, as subjects are unable to inhibit a previously reinforced 
response.  Some research, however, has suggested that adolescents are not hypersensitive to drug 
reward.  Our lab has shown that adolescent rats are more motivated to lever press for non-drug 
rewards (e.g., food pellets and sweetened condensed milk) compared to their adult-counterparts 
(Westbrook et al., 2018).  However, results from subsequent experiments showed that 
adolescents had greater behavioral flexibility and had similar sensitivity to reward value 
compared to adults. Therefore, results from these latter studies do not support theories of 
adolescent vulnerability to reward.  It is likely that other factors such as pubertal status and 
motivational states may influence adolescent behavior in rodents (Westbrook et al., 2018).  
Research has reported that cannabis use reduces anxiety (Johns et al., 2001).  Therefore, 
it is likely that individuals with a depressive disorder may be more inclined to use cannabis, as 
they are more prone to develop anxiety compared to the average individual.  Schneider et al. 
(2005) investigated the effects of long-term THC exposure during the juvenile period through 
mid-adolescence (Postnatal day (P) 15 –P 40) and reported long-lasting changes in anxiety-
related behaviors when tested in adulthood.  During the adolescent period, rats received 20 
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intraperitoneal injections (i.p.) that were delivered irregularly (e.g., rats received a single 
injection of THC on some days, but on other days they did not receive any THC or they received 
two injections) so as to mimic irregular consumption in humans.  In this study, rats that were 
exposed to THC during adolescence spent significantly less time in the center of an open field 
arena (OFA) and showed reductions of exploratory behavior, which was considered to be an 
index of anxiety-related activity.  
Human and animal studies have also examined the effects of THC following acute 
exposure.  For example, oral THC (0, 5, 15 and a high dose of either 25 or 30 mg) was 
administered to 30 healthy female and male participants and physiological measures and 
symptom ratings were assessed 1 hr post drug administration (Fogel et al., 2017).  Participants 
who consumed THC reported both positive and negative experiences (e.g., a good effect or a bad 
effect according to the Visual Analog Scale or VAS).  In an animal study, male rats were 
injected with increasing doses of CP 55,940 (0.125, 0.1 and 0.075 mg/kg; i.p.) and were 
evaluated on an elevated plus maze (EPM) 30 min post drug administration.  Drug-treated rats 
spent less time in the open arms and showed reduced locomotor activity compared to the vehicle 
group (Arevalo et al. 2001).  O’Brien et al. (2013) also administered THC (2.5 mg/kg; i.p.) to 
rats and reported an anxiogenic response when animals were tested on the light-dark (LD) test.  
In this experiment, THC-treated animals spent significantly less time in the light box than control 
animals, indicating an anxiogenic effect.  Furthermore, Hložek et al. (2017) reported that forced 
exposure of THC via oral gavage caused a reduction of locomotor activity in the OFA.  Although 
these experiments have reported similar effects on locomotor activity and anxiety, it is unclear if 
these behaviors are specific to age and sex. It is important to address this deficiency, as these two 
factors may contribute to a heightened vulnerability to drug use (Casey et al. 2008). 
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Several rodent models have already investigated the effects of THC, but most of these 
studies have used the parenteral route of administration.  Indeed, very few studies exist on the 
behavioral effects of THC following volitional, oral intake.  Some research has examined the 
effects of THC via oral gavage; however, this is not a sufficient model of drug self-
administration as subjects are not allowed to administer the drug themselves.  Oral gavage is also 
likely a stressful procedure, thereby further influencing the animal’s behavior.  For example, rats 
who experienced negative affective states showed reductions in operant responding for sucrose 
(Bai et al., 2019). Certainly, this method of drug administration may induce undesirable 
behaviors that are not attributed to the drug itself.   
The purpose of this present study was to show that rats would quickly and voluntarily 
consume THC-laced crackers that would subsequently produce a psychoactive effect.  Nelson et 
al. (2019) already reported that this method of THC administration induces a behavioral effect in 
rats, as THC-treated animals increased their food intake.  This study, however, investigated the 
behavioral effects of THC after chronic exposure. Our goal was to provide additional evidence 
that this model of volitional drug administration could be used to detect the acute, psychoactive 
effects of THC.  Here, we used a rat model to determine if THC-laced crackers would alter 
locomotor activity in an OFA and anxiety-like behavior on an EPM. We hypothesized that THC 
would cause significant reductions in locomotor activity in the OFA accompanied by reduced 
exploration of open arms on the EPM. We also determined that adolescents may be more 
sensitive to the effects of THC compared to their adult counterparts.  
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MATERIALS AND METHODS 
Subjects 
Animals were male (n = 81) and female (n = 72) Sprague-Dawley rats born in-house 
from male and female breeders originally obtained from Envigo (Indianapolis, IN).  Subjects 
were weaned on P 22 and paired housed with ad libitum access to food and water.  They 
remained in a temperature-controlled room on a 12-hr reversed light/dark cycle (lights off at 
0900) and were weighed daily beginning on P 25.  Pubertal onset was estimated by checking 
vaginal opening in females and preputial separation in males (Castellano et al., 2011) starting on 
P 30 and continuing until all rats reached puberty (figure 1). All experimental procedures were 
approved by the Institutional Animal Care and Use Committee at the University of Illinois, 
Urbana- Champaign, and were consistent with the Guide for the Care and Use of Laboratory 
Animals (National Research Council, 2011). 
 
Apparatus  
Locomotor activity was measured in an OFA, which consisted of a clear acrylic box (41 
X 41 X 41-cm) and two surrounding photobeam frames (16 beams/dimension; 2.5 cm between 
beams).  The arena was located inside a sound-attenuating cubicle (76 X 80 X 63-cm) that was 
illuminated by a red ceiling light (4W).  Mounted on the ceiling was a video camera that was 
used to record all behavioral sessions; a speaker was also mounted near the ceiling and it was 
used to play a tone (~53.5 dB) for the duration of test sessions in order to mask extraneous noise.  
To analyze these tests, each OFA was linked to a nearby computer running software (Truscan, 
2.01, Coulbourn Instruments) that recorded photobeam breaks in the upper and lower planes at a 
500 ms sampling rate.  Lastly, animals were transferred from their colony to the testing room in 
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groups of 2 or 4 and they were allowed a 5-min habituation period where they remained 
undisturbed before testing.  Data from 15 adolescents (10 females, 5 males) and 25 adult rats (11 
females, 14 males) were excluded from the final analysis due to technical problems or because 
the rat did not eat its assigned dose of the THC-laced cracker on the testing day, or because they 
did not have a litter-matched rat in all other groups.   
Anxiety-related behavior was measured in an EPM after drug-treated animals received 
their second exposure to the highest dose of THC (vehicle or 10.0 mg/kg cracker).  The 
apparatus was a wooden, plus-shaped maze that was painted black and elevated 94 cm above the 
floor.  Two closed arms and two open arms that were both 110 cm long formed an unenclosed 
central square (10.16 × 10.16 cm).  The closed arms were supported by three wooden walls that 
were 42.5 cm high, whereas the open arms remained completely unprotected.  Experiments were 
conducted in a dark room that was dimly illuminated with white light (~40.1 lm) and were 
analyzed using tracking software (Anymaze, 4.99, Stoelting Company).  Data from 22 
adolescents (14 females, 8 males) and 29 adult rats (13 females, 16 males) were excluded from 
the final analysis due to rats not eating their THC-laced cracker on the testing day or because 
they did not have a litter-matched rat in all other groups. 
  
Drug Treatment and Behavioral Testing 
Before drug administration, rats were temporarily separated by Plexiglas cage dividers so 
that each individual’s drug intake could be accurately monitored.  The contents of a 10 mg 
dronabinol liquigel capsule, which are commercially available (Actavis Pharm, Inc.; Parsippany, 
NJ, USA) and contain a synthetic form of THC, were extracted using a 1 ml syringe.  The 
capsule contents were then suspended in sesame oil at concentrations of .016 mg/µL, .026 mg/ 
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µL, and .051 mg/ µL to prepare the 3-, 5-, and 10.0 mg/kg doses. The remaining stock solution 
was pipetted onto a cracker (Fudge Brownie Goldfish Grahams, Pepperidge Farm) according to 
the animal’s body weight.  At each dose, the concentration was increased so that animals would 
receive a similar amount of stock solution on their cracker.  Sesame oil vehicle was administered 
isovolumetrically to all corresponding doses for control crackers. 
Adolescent and adult rats of both sexes were assigned to one of two treatment groups – 
control or THC – so that most groups were represented in each litter.  Drug-treated animals 
received intermittent access to THC once every three days, starting at P36 until P45 for 
adolescents (± 1 day) or P77 – P86 for adults (± 1 day).  Vehicle (sesame oil impregnated) 
crackers were administered for two days after each testing session.  Control rats received vehicle 
crackers throughout the entire experiment.  According to Hložek et al. (2017), blood levels of 
THC administered reach their peak 90-120 min after oral gavage in rats, so behavioral tests were 
conducted 90 min after cracker self-administration.  Before testing, animals were transported 
individually from their colony to a testing room where they remained for a 5-min acclimation 
period.  For the EPM, rats were placed in the center with their head facing towards an open arm 
and they were allowed to explore the maze freely for 5 min. 
 
Data Analysis  
Horizontal photobeam breaks were used to measure ambulation and vertical photobeam 
breaks were used to measure rearing, which occurred when rats stood on their hindlimbs.  Total 
distance traveled (m), total number of open arm entries, and % time spent the open arms were 
evaluated as measures of anxiety-related behaviors.  Data for all behavioral tests were analyzed 
with SAS Statistical Software (SAS Institute Inc., Cary, NC) and are presented as mean ± SEM.  
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Mixed linear models were utilized for all dependent behavioral measures with litters comprising 
a random variable. Locomotor activity was analyzed with a three-way repeated measures 
ANOVA, with treatment, time, and sex as the three factors.  Dose response curves for both 
ambulation and rearing were analyzed with a repeated four-way ANOVA, with testing day, age, 
sex, and treatment as the four factors.  Lastly, anxiety-related behavior was also analyzed with a 
three-way ANOVA, with treatment, age, and sex as three factors. Significance was determined 
as p ≤ 0.05 for all tests. 
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RESULTS 
Puberty  
Figure 1 shows average pubertal onset was 36.1 days for female (range: 33-43) and 43.8 days for 
male rats (range: 40-48).  For animals who consumed THC, average pubertal onset was 35.9 
days for female (range: 34-37) and 44.2 days for male rats (range: 43-46).  Three-way ANOVAs 
revealed a significant main effect for sex, F(1, 74) = 362.49, p < .0001.  
 
Locomotor Activity  
Shown in Figure 2 are the individual time series data for 20 female (10 THC and 10 
vehicle) and 21 male (10 THC and 11 vehicle) adolescent rats during each session.  Three-way 
ANOVAs for the first open field session (vehicle or 3.0 mg/kg cracker) revealed significant main 
effects for treatment, F(1, 37) = 6.69, p = .0138; and time, F(3, 37) = 118.26, p < .0001, as well 
as a significant sex  time interaction, F(3, 37) = 3.01, p = .0421 in locomotor activity.  There 
was also a main effect of time for rearing, F(3, 37) = 53.56, p < .0001, and a significant sex  
treatment  time interaction, F(3, 37) = 3.24, p = .0328.  THC-treated rats in the second session 
(vehicle or 5.0 mg/kg cracker) showed reduced ambulation, F(1, 37) = 5.25, p = .0278; data also 
revealed a main effect for time in both ambulation, F(3, 37) = .31, p < .0001, and in rearing, F(3, 
37) = 29.64, p < .0001.  Furthermore, results from the last session (vehicle or 10.0 mg/kg 
cracker) showed a significant main effect for time, F(3, 37) = 103.12, p < .0001, as well as a 
significant treatment  time interaction, F(3, 37) = 3.12, p = .0373.  Post hoc analysis revealed 
that THC-treated animals significantly reduced ambulation, but only during the first time 
interval; and, VEH-treated animals significantly reduced ambulation during time intervals 1-3.  
There was also a main effect of time for rearing, F(3, 37) = 42.27, p < .0001; and treatment F(1, 
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37) = 7.40, p = .0099, along with a significant treatment  time interaction, F(3, 37) = 3.68, p = 
.0204. 
 Figure 3 shows the time series data for 19 females (9 THC and 10 vehicle) and 22 male 
(11 THC and 11 vehicle) adult rats. Three-way ANOVA revealed significant main effects for 
time, F(3, 37) = 140.87, p < .0001, as well as a significant sex  time interaction, F(3, 37) = 
4.94, p = .0055 during the first open field session.  THC-treated animals reared less than 
controls, F(1, 37) = 5.75, p = .0217, and all groups reduced rearing across the four time intervals, 
F(3, 111) = 44.72, p < .0001.  For ambulation during the second session, there was a main effect 
for time, F(3, 37) = 139.28, p <.0001, along with a significant sex  time interaction F(3, 37) = 
4.21, p = .0017 and a significant treatment  time interaction F(3, 37) = 4.03, p = .0141.  Both 
THC and VEH rats reduced ambulation at time intervals 1-3.  Moreover, all groups showed less 
rearing within the four time intervals F(3, 36) = 67.51, p < .0001.  Results from the last session 
indicate a main effect for sex in ambulation, F(1, 37) = 9.73, p = .0035, as well as a significant 
main effect of time in rearing, F(3, 111) = 80.90, p < .0001. 
Four-way ANOVAs for dose response curves (figure 4) also revealed significant main 
effects for age, F(1, 74) = 32.47, p < .0001; and treatment, F(1, 74) = 13.22, p = .0004, as well as 
a significant interaction between age and sex, F(1, 74) = 4.20,  p =  .0440, and age and session, 
F(2, 74) = 6.44,  p =  .0026.  Post hoc analysis indicate that adult females ambulated more than 
any other group.  Adult rats also reared more than adolescents, F(1, 74) = 49.51,  p < .0001, and 
there was a significant session  age interaction, F(2, 74) = 6.53,  p = .0025. 
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Elevated Plus Maze  
Subjects used to examine anxiety-related behavior in the EPM were adolescent and adult 
rats (figure 5).  Overall, adolescent female rats (10 vehicle and 6 THC) were more active than 
adolescent males (9 vehicle and 9 THC), F (1, 30) = 6.06, p = .0198. There was also a tendency 
for adolescent THC-treated rats to have fewer open arm entries, however these results were not 
significant.  Furthermore, adult rats (10 female VEH and 7 female THC; 10 male VEH and 10 
male THC) that received THC showed a tendency for reduced open arm entries and less time 
spent in the open arms, however these results were also not significant.   
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DISCUSSION 
This study used adolescent and adult rats of both sexes to investigate the psychoactive 
effects of THC following volitional, oral intake.  Results from the OFA show that THC-treated 
adolescent rats significantly reduced ambulation during the first two sessions (3- and 5.0 mg/kg), 
however this effect was not observed at the highest dose.  Instead, rats who consumed 10.0 
mg/kg of THC significantly reduced rearing compared to the vehicle group.  It is possible that 
the effects of THC were undetectable during the final session.  Here, all groups reduced their 
exploration of the maze after approximately 10 min of testing, as they were habituated to the 
apparatus.  Our time series graph shows that THC-treated rats significantly reduced ambulation 
during the first half of the session (figure 2), but this effect was alleviated during the last two 
time intervals.  Given this information, we may need to employ a different method in order to 
examine the repeated, locomotive effects of this drug.  For example, instead of testing subjects 
three different times using the same test, future research should consider examining this effect in 
only one dose per group (e.g., a subset of rats gets either 3-, 5-, or 10.0 mg/kg).   
Adult drug-treated rats also showed significant reductions in ambulation, but only during 
the first 15 min of the second session (vehicle or 5.0 mg/kg cracker).  Furthermore, these 
subjects reduced rearing 90 min after consuming the lowest dose of THC (vehicle or 3.0 mg/kg 
cracker).  The dose response curves clearly shows these age-related differences following THC 
consumption.  Therefore, it is likely that adolescents are showing a greater sensitivity to the 
behavioral effects of THC. 
Research has shown that high doses of THC (5–30 mg/kg, i.p.) lead to a reduction of 
locomotor activity.  However, when THC-gelatin was administered to adolescent rats (1.0, 1.5, 
and 2.0 mg/15ml gelatin), there were no observed differences between control and THC-treated 
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rats in locomotor activity (Kruse et al., 2019).  In this study, rats received 4 hr access to THC and 
were immediately evaluated in an OFA for 60 min, a time point when rats have habituated to the 
apparatus.  Similar to our final open field session, which is when the 10 mg/kg dose was tested, it 
is likely that any potential drug effect was obscured due to habituation.  Results from the EPM 
indicated no statistically significant differences in anxiety-related behaviors following THC 
exposure.  However, there was a tendency for both male and female adolescent THC-treated rats 
to have less open arm entries compared to their vehicle group.  Female adolescent rats who 
consumed 10.0 mg/kg of THC tended to spend less time in the open arms and they had increased 
exploration of the maze compared to their male counterparts (p = .0198).  Furthermore, adult 
THC-treated rats also tended to have less open arm entries and spend less time in the open arms.  
Although the effects of THC on anxiety-related behavior were not statistically significant, the 
tendency for THC-treated animals to have fewer open arm entries and spend less time in the 
open arms has been previously reported in the literature (0.125, 0.1 and 0.075 mg/kg; i.p.) 
(Arevalo et al. 2001). 
It is possible that we were unable to find any significant differences in anxiety-related 
behaviors due to limitations of our experiment.  In fact, one of the major caveats of this study 
was that almost half of the animals would not eat the 10.0 mg/kg cracker the second time it was 
administered (i.e., prior to the EPM test).  We determined that this dose of THC was aversive to 
rats, since they would typically eat their vehicle crackers two days prior.  Specifically, rats could 
have had a negative experience after consuming their first 10.0 mg/kg cracker, or they may have 
acquired a taste aversion to the high dose of THC.  Previous literature has already shown that this 
drug may be aversive in rats.  For example, Han et al. (2017) reported that THC (1, 3, or 
5 mg/kg, i.p.) produced dose-dependent conditioned taste and conditioned place aversion in rats.  
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If our subjects did not consume their THC-laced cracker, they were not included in the analysis; 
so, all THC groups had a lower sample size relative to their vehicle group.  Consequently, it is 
likely that we were unable to detect any statistical significance in the EPM due to this 
unbalanced and under-powered design. 
We also lost data due to subjects falling off the maze: 6 vehicle rats (2 females and 4 
male adolescents) and 2 THC rats (1 female adolescent and 1 male adult) were excluded for this 
reason.  It is possible that a high dose of THC (e.g., 10.0 mg/kg) impaired motor function.  Irmia 
et al. (2015) reported dose-dependent increases in motor impulsivity following THC exposure.  
In this study, she administered repeated cycles of THC (ten 14-day cycles of Δ9-THC dosing) to 
rats and found deficits in motor activity via the 5-Choice Serial Reaction Time Task (5-CSRTT).  
However, it is important to note that this effect was observed after long-term exposure to THC.  
Furthermore, it could be the case that this response was not mediated at all by THC, as vehicle 
rats also fell off the EPM.   
In the present study, male and female rats in both groups displayed similar effects of 
locomotor activity and anxiety-related behavior.  Previous literature has also suggested a lack of 
sex differences following THC exposure.  For example, Wiley et al. (2007) administered THC 
(10.0mg/kg; i.p.) to rats 60 min prior to testing and reported that both sexes showed similar 
reductions of locomotor activity.  Javadi-Paydar et al. (2018) also reported similar motoric 
effects in male and female rats that inhaled THC (12.5, 25, 50, 100, 200 mg/mL) 40 min prior to 
testing.   
Some research, however, has shown the behavioral effects of THC to be greater in 
females than in males.  Harte-Hargrove et al. (2012) reported that females spent significantly less 
time in the open arms than male rats, indicating a heightened sensitivity to the effects of THC 
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(15 mg/kg; i.p.).  Furthermore, when Craft et al. (2008) examined the behavioral effects of THC 
(5- or 10 mg/kg; i.p.) in male and female gonadectomized rats, she reported differential effects in 
rats that were chronically treated with a hormone.  Testosterone-treated male rats showed 
significantly less locomotor suppression than those with no hormone replacement; conversely, 
estradiol enhanced THC’s antinociceptive properties in female rats, but had no change on THC’s 
motoric effects. Therefore, it is likely that sex differences in the effects of THC are specific to 
the behavioral measure that is being tested.  It could also be the case that we did not observe any 
sex differences due to the potential limitations of our experiment, which includes rats not eating 
their prior to EPM testing and rats falling off the maze.      
Despite these limitations, this study still offers additional support for a useful model of 
THC self-administration by demonstrating age- and dose-dependent hypolocomotive effects 
following drug consumption.  Edible use is becoming increasingly popular, and this experiment 
employs a volitional, oral intake model that may be used to examine the potential long-term 
effects of THC.  Future research, however, should avoid extremely high doses of THC in this 
experimental design.  
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FIGURES 
 
 
 
 
 
 
 
 
Fig. 1. Average pubertal day for adolescent- and adult- onset rats.  Only adolescent rats received 
THC around pubertal onset, *p <.0001, females vs males collapsed across age and treatment 
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Fig. 2. Effects of THC on behavior in the open-field arena.  Shown are the individual time series data for adolescent rats 
(n=10 -11/group) during each session where THC or vehicle was given 90 min prior to the start of the test. A, Total 
ambulation during the first session (vehicle or 3.0 mg/kg cracker), *p = .0138, THC vs. VEH collapsed across sex. B, 
Total rearing during the first session (vehicle or 3.0 mg/kg cracker), *p = .0138, Male THC time interval 1 vs. 2. C, 
Total ambulation in the second session (vehicle or 5.0 mg/kg cracker), *p = .0278, THC vs. VEH collapsed across sex. 
D, Total rearing during the second session (vehicle or 5.0 mg/kg cracker). E, Total ambulation in the last session 
(vehicle or 10.0 mg/kg cracker), *p = .0373, THC-treated rats reduced ambulation vs. the first time interval, collapsed 
across sex. F, Total rearing in the last session (vehicle or 10.0 mg/kg cracker), *p = .0099, THC vs. VEH collapsed 
across sex. 
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Fig. 3. Effects of THC on behavior in the open-field arena.  Shown are the individual time series data for adult rats 
(n=9 -11/group) during each session where THC or vehicle was given 90 min prior to the start of the test. A, Total 
ambulation during the first session (vehicle or 3.0 mg/kg cracker) B, Total rearing during the first session (vehicle or 
3.0 mg/kg cracker), *p = .0217, THC vs. VEH collapsed across sex. C, Total ambulation in the second session 
(vehicle or 5.0 mg/kg cracker), *p = .0141, THC time interval 1 vs. the 2 and 3, collapsed across sex. D, Total rearing 
during the second session (vehicle or 5.0 mg/kg cracker). E, Total ambulation in the last session (vehicle or 10.0 
mg/kg cracker). F, Total rearing in the last session (vehicle or 10.0 mg/kg cracker). 
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Fig. 4. Cumulative effects of THC on behavior in the open-field arena. Shown are dose response 
curves for ambulation and rearing (vehicle groups not shown) in both adolescent and adult rats 
where THC or vehicle was given 90 min prior to the start of the test. A, Total ambulation in each 
session, **p < .0001, adolescents vs. adults. B, Total rearing in each session, **p < .0001, 
adolescents vs. adults. 
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Fig. 5. Anxiety-related behavior in adolescent and adult rats of both sexes. A, Total distance traveled, 
number of open arm entries, and time in open arms for adolescent rats of both sexes, *p = .0198, 
adolescent females vs. adolescent males, total distance traveled. B, Total distance traveled, number of 
open arm entries, and time in open arms for adult rats of both sexes. 
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